Feeling the adrenaline after submitting a grant application. Honestly, I am just proud of myself for finishing it, and for gaining so much since my previous application. Thanks for the reminder 😊 #scicomm #phdlife #universityofhelsinki
PhD students. One working in neuroscience and the other in immuno-oncology. Possible future collaborators?! 🤔🤔 #scientistswhoselfie #universityofhelsinki #phdlife #scicomm
”Syöpä voidaan saada kuriin jopa pysyvästi” – Immuno-onkologisten hoitojen tehostamiseen satsataan 10 miljoonaa euroa #tutkimus #helsinginyliopisto #cancerio https://t.co/482JuZeORt
Cancer IO is a new multimillion Immuno-Oncology (IO) collaboration project boosting the Finnish IO landscape! Find out more from: https://t.co/Hnc07YjUBe @helsinkiuni #cancer #cancerresearch #immunotherapy #immunooncology #universityofhelsinki #helsinki #businessfinland
Research is beautiful. A lunchroom discussion about sausage soup somehow lead to helpful information about analyzing my data. #HelsinkiUni #phdlife
Learning how to tweet after a busy day of research 😅 #scientist #PhD #HelsinkiUni @vlfuller
We now understand better how breast cancer spreads. Researchers defined a cancer invasion machinery, which is orchestrated by a frequently mutated cancer gene called Ras.
In women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related deaths. Inherited breast cancer risk should be assessed in a more comprehensive manner, a study finds.
We now understand better how breast cancer spreads. @JuhaKlefstrom and his group defined a cancer invasion machinery, which is orchestrated by a frequently mutated cancer gene called Ras. #HelsinkiHealth #cancer #breastcancer #MedTwitter @amchelsinki https://t.co/xMbzsO8aVx
We now understand better how breast cancer spreads. @JuhaKlefstrom and his group defined a cancer invasion machinery, which is orchestrated by a frequently mutated cancer gene called Ras. #HelsinkiHealth #cancer #breastcancer #MedTwitter @amchelsinki https://t.co/xMbzsO8aVx
A machine learning model developed in Finland can help us treat cancer more effectively.
The new findings of @helsinkiuni researchers help understand the mechanisms of cancer spreading and reveal a cancer vulnerability. @JuhaKlefstrom #HelsinkiHealth https://t.co/QLBv6Fe0nT
The new findings of @helsinkiuni researchers help understand the mechanisms of cancer spreading and reveal a cancer vulnerability. @JuhaKlefstrom #HelsinkiHealth https://t.co/QLBv6Fe0nT
Hannu Koistinen lab Prostatic Proteases aim is to identify novel prostate cancer markers and drug targets. Read more: https://t.co/fOk1Uj7TiJ #helsinkihealth #helsinkiuni
Hannu Koistinen lab Prostatic Proteases aim is to identify novel prostate cancer markers and drug targets. Read more: https://t.co/fOk1Uj7TiJ #helsinkihealth #helsinkiuni
Currently, nanomedicines are making their ways to our everyday life, and that is a good thing. They help to target the drugs to the exact right place in the body and can be used in significantly smaller doses. Nanomedicines can change the treatment of for example cancer, diabetes and cardiovascular diseases, says Professor Hélder Santos.
Currently, nanomedicines are coming more and more into our everyday life, and that is a good thing. They may alter the treatment of known diseases such as cancer and diabetes. “If drugs can be precisely targeted to the exact right place in the body, we can direct our treatments in a more efficient way and use significantly smaller doses – and consequently have fewer side effects,” says professor Hélder Santos.
Researchers from aaltouniversity universityofhelsinki and uniturku have developed a machine learning model enabling medical professionals to…
RT @helsinkiuni: A machine learning model developed in Finland can help us treat cancer more effectively. #HelsinkiHealth #AI #cancer #health @UniTurku @AaltoUniversity https://t.co/sYpwltV3OU
RT @helsinkiuni: A machine learning model developed in Finland can help us treat cancer more effectively. #HelsinkiHealth #AI #cancer #health @UniTurku @AaltoUniversity https://t.co/sYpwltV3OU